tiprankstipranks
Bajaj Healthcare Ltd (IN:BAJAJHCARE)
:BAJAJHCARE
India Market
Want to see IN:BAJAJHCARE full AI Analyst Report?

Bajaj Healthcare Ltd (BAJAJHCARE) Price & Analysis

4 Followers

BAJAJHCARE Stock Chart & Stats

₹418.50
-₹31.80(-5.51%)
At close: 4:00 PM EST
₹418.50
-₹31.80(-5.51%)

Bulls Say, Bears Say

Bulls Say
Diverse Manufacturing & Revenue StreamsBajaj Healthcare's integrated manufacturing across APIs, intermediates, finished dosages and contract manufacturing provides durable revenue diversification. Serving both domestic and export markets with large-scale capabilities supports steadier order flow, reduces single-customer risk and underpins long-term industrial competitiveness.
Improving LeverageA move to ~0.47 debt-to-equity from prior elevated levels materially improves solvency and lowers refinancing strain. Stronger leverage supports greater financial flexibility for working capital, capex or R&D, reduces interest burden in future cycles and strengthens resilience to industry downturns.
Revenue Recovery & Margin ImprovementThe FY2026 revenue rebound and higher gross margin suggest recovering demand, improved product mix or better cost control. With operating margins at mid-teens on EBITDA, the company can convert operational leverage into sustained cash generation if below-the-line volatility is managed, supporting durable profitability.
Bears Say
Weak Net ProfitabilityA very low net margin and a prior major loss signal fragile bottom-line durability. Low net profitability reduces retained earnings, weakens returns to shareholders and leaves little buffer against cost or demand shocks, undermining long-term earnings quality despite healthier gross and EBITDA margins.
Negative Free Cash FlowPersistent negative free cash flow and a history of weak cash conversion increase funding and liquidity risk. Even with operating cashflow recovery, negative FCF limits ability to pay down debt, invest organically or return capital, potentially forcing reliance on external financing during adverse cycles.
Volatile Financial PerformanceHistory of uneven revenue and episodic losses reduces predictability for planning and raises the company's effective cost of capital. Such volatility can strain supplier, customer and lender relationships and complicate long-term strategic execution and investment decisions.

Bajaj Healthcare Ltd News

BAJAJHCARE FAQ

What was Bajaj Healthcare Ltd’s price range in the past 12 months?
Bajaj Healthcare Ltd lowest stock price was ₹272.45 and its highest was ₹552.55 in the past 12 months.
    What is Bajaj Healthcare Ltd’s market cap?
    Bajaj Healthcare Ltd’s market cap is ₹11.56B.
      When is Bajaj Healthcare Ltd’s upcoming earnings report date?
      Bajaj Healthcare Ltd’s upcoming earnings report date is Aug 04, 2026 which is in 20 days.
        How were Bajaj Healthcare Ltd’s earnings last quarter?
        Bajaj Healthcare Ltd released its earnings results on May 08, 2026. The company reported -₹7.16 earnings per share for the quarter, missing the consensus estimate of N/A by -₹7.16.
          Is Bajaj Healthcare Ltd overvalued?
          According to Wall Street analysts Bajaj Healthcare Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Bajaj Healthcare Ltd pay dividends?
            Bajaj Healthcare Ltd pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.24%. See more information on Bajaj Healthcare Ltd dividends here
              What is Bajaj Healthcare Ltd’s EPS estimate?
              Bajaj Healthcare Ltd’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Bajaj Healthcare Ltd have?
              Bajaj Healthcare Ltd has 33,662,663 shares outstanding.
                What happened to Bajaj Healthcare Ltd’s price movement after its last earnings report?
                Bajaj Healthcare Ltd reported an EPS of -₹7.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.883%.
                  Which hedge fund is a major shareholder of Bajaj Healthcare Ltd?
                  Currently, no hedge funds are holding shares in IN:BAJAJHCARE
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Bajaj Healthcare Ltd

                    Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, phlebotropic drug, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

                    Bajaj Healthcare Ltd (BAJAJHCARE) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Bliss Gvs Pharma Limited
                    Hester Biosciences Limited
                    Jagsonpal Pharmaceuticals Ltd.
                    Syncom Formulation (India) Ltd.
                    Themis Medicare Limited
                    Popular Stocks